The Interleukin-18 promoter -607C>a polymorphism contributes to nasopharyngeal carcinoma risk: Evidence from a meta-analysis including 1,886 subjects

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 12, 2013, Pages 7577-7581

  Guo, Xu Guang ^a   Xia, Yong ^a  

^a GUANGZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Interleukin 18; Meta analysis; Nasopharyngeal carcinoma; Polymorphism; Risk

Indexed keywords

INTERLEUKIN 18;

ARTICLE; GENETIC POLYMORPHISM; GENETICS; HUMAN; META ANALYSIS; NASOPHARYNX CARCINOMA; NASOPHARYNX TUMOR; PROGNOSIS; PROMOTER REGION; RISK FACTOR;

HUMANS; INTERLEUKIN-18; NASOPHARYNGEAL NEOPLASMS; POLYMORPHISM, GENETIC; PROGNOSIS; PROMOTER REGIONS, GENETIC; RISK FACTORS;

EID: 84893391106     PISSN: 15137368     EISSN: None     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.12.7577     Document Type: Article

References (25)

1. Bombardieri M, McInnes IB, Pitzalis C (2007). Interleukin-18 as a potential therapeutic target in chronic autoimmune/inflammatory conditions. Expert Opin Biol Th, 7, 31-40.
2. Chan AT, Teo PM, Johnson PJ (2002). Nasopharyngeal carcinoma. Ann Oncol, 13, 1007-15.
3. Cochran WG (1968). The effectiveness of adjustment by subclassification in removing bias in observational studies. Biometrics, 24, 295-313.
4. DeSantis C, Naishadham D, Jemal A (2013). Cancer statistics for African Americans, 2013. CA-Cancer J Clin, 63,151-66.
5. Dinarello CA, Novick D, Kim S, Kaplanski G (2013). Interleukin-18 and IL-18 Binding Protein. Front Immunol, 4, 289.
6. Du B, Zhao J, Wei Y (2012). Interleukin-18 gene genetic polymorphisms and risk Of nasopharyngeal carcinoma in Han population from Sichuan China. Med J West China, 25, 1683-6.
7. Egger M, Smith G, Schneider M, Minder C. (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
8. Farhat K, Hassen E, Bouzgarrou N, et al (2008). Functional IL-18 promoter gene polymorphisms in Tunisian nasopharyngeal carcinoma patients. Cytokine, 43, 132-7.
9. Fariasa TD, Canto LM, Medeiros MD, et al (2013). Lack of association between interleukin-18 polymorphisms and rheumatoid arthritis. Rev Bras Reumatol, 53, 199-205.
10. Jemal A, Bray F, Center MM, et al (2011). Global Cancer Statistics. CA-Cancer J Clin, 61, 69-90.
11. Ji J, Lee W (2013). Interleukin-18 gene polymorphisms and rheumatoid arthritis: A meta-analysis. Gene, 523, 27-32.
12. Ma Y, Zhang B, Tang R, et al (2012). Interleukin-18 promoter polymorphism and asthma risk: a meta-analysis. Mol Biol Rep, 39, 1371-6.
13. Mantel N, Haensze W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer I, 22, 719-48.
14. Mi Y, Yu Q, Yu M, et al (2011). Review and pooled analysis of studies on-607 (C/A) and-137 (G/C) polymorphisms in IL-18 and cancer risk. Med Oncol, 28, 1107-15.
15. Nong L, Luo B, Zhang L, Nong H (2009). Interleukin-18 gene promoter polymorphism and the risk of nasopharyngeal carcinoma in a Chinese population. DNA Cell Biol, 28, 507-13.
16. Pan G, Luo B, Teng Y, Liang L (2013). Research on interleukin-18 gene promotoe polymorphisms and genetic susceptibility of nasopharngeal carcinoma. Lab Med, 28, 457-61.
17. Pratesi C, Bortolin MT, Bidoli E, et al (2006). Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type. Cancer Immunol Immun, 55,23-30.
18. Song G, Bae S, Kim J, Lee Y (2013). Interleukin-4, interleukin-4 receptor, and interleukin-18 polymorphisms and rheumatoid arthritis: a meta-analysis. Immunol Invest, 42, 455-69.
19. Song G, Choi S, Ji J, Lee Y (2013). Association between interleukin-18 polymorphisms and systemic lupus erythematosus: a meta-analysis. Mol Biol Rep, 40, 2581-7.
20. Srivastava S, Salim N, and Robertson MJ (2010). Interleukin-18: Biology and Role in the Immunotherapy of Cancer. Curr Med Chem, 17, 3353-7.
21. Stuck AE, Rubenstein LZ, and Wieland D (1998). Bias in meta-analysis detected by a simple, graphical test. Asymmetry detected in funnel plot was probably due to true heterogeneity. BMJ, 316, 469.
22. Thakkinstian A, McElduffP, Este C, et al (2005). A method for meta-analysis of molecular association studies. Stat Med, 24, 1291-306.
23. Wang M, Zhu X, Wang L, Lin Y (2013). The-607C/A Polymorphisms in Interleukin-18 Gene Promoter Contributes to Cancer Risk: Evidence from A Meta-Analysis of 22 Case-Control Studies. Plos One, 8, e76915.
24. Yang X, Qiu M, Hu J, et al (2013). Association of interleukin-18 gene promoter-607 C
25. Yang Y, Chang T, Chen T, et al (2013). Genetic variants in interleukin-18 gene and risk for cervical squamous cell carcinoma. Hum Immunol, 74, 882-7.